Core Laboratories (CLB) Current Leases (2022 - 2026)
Core Laboratories filings provide 5 years of Current Leases readings, the most recent being $12.1 million for Q1 2026.
- On a quarterly basis, Current Leases rose 3.8% to $12.1 million in Q1 2026 year-over-year; TTM through Mar 2026 was $12.1 million, a 3.8% increase, with the full-year FY2025 number at $11.5 million, up 7.17% from a year prior.
- Current Leases hit $12.1 million in Q1 2026 for Core Laboratories, up from $11.5 million in the prior quarter.
- In the past five years, Current Leases ranged from a high of $12.1 million in Q1 2026 to a low of $9.8 million in Q3 2023.
- Median Current Leases over the past 5 years was $11.4 million (2024), compared with a mean of $11.1 million.
- Biggest five-year swings in Current Leases: dropped 13.03% in 2023 and later grew 16.76% in 2024.
- Core Laboratories' Current Leases stood at $11.7 million in 2022, then fell by 13.03% to $10.2 million in 2023, then grew by 5.06% to $10.7 million in 2024, then rose by 7.17% to $11.5 million in 2025, then rose by 5.6% to $12.1 million in 2026.
- The last three reported values for Current Leases were $12.1 million (Q1 2026), $11.5 million (Q4 2025), and $11.5 million (Q3 2025) per Business Quant data.